We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

High Cardiovascular Risk Management and Salt Reduction in Rural Villages in China

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01259700
First Posted: December 14, 2010
Last Update Posted: February 17, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
The George Institute for Global Health, China
  Purpose
Cardiovascular disease is the leading cause of death in China. At the village level, strategies for the control of cardiovascular disease are mostly absent. National clinical guidelines for the management of hypertension and cardiovascular disease are rarely disseminated to, or implemented by, the village primary care providers. Salt reduction has greater potential in rural China than almost anywhere else in the world. Very high levels of salt consumption, very little use of processed food and most dietary salt deriving from home cooking makes the removal of salt from the diet easier, cheaper and more worthwhile than in almost any other setting. The two large-scale cluster-randomized controlled trials proposed here will precisely and reliably define the effect of two highly plausible intervention strategies on important clinical outcomes. The evidence provided by the project will form the basis for policy setting that has the potential to greatly reduce the occurrence of vascular disease in rural China and take an important step towards balancing the rural urban divide in health and healthcare.

Condition Intervention
Cardiovascular Disease Behavioral: High-risk patient standardized management package Behavioral: Community based salt reduction program

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: China Rural Health Initiative: High Cardiovascular Risk Management and Salt Reduction in Rural Villages in China -- Two Parallel Large Cluster Randomized Controlled Trials

Resource links provided by NLM:


Further study details as provided by The George Institute for Global Health, China:

Primary Outcome Measures:
  • Mean systematic blood pressure level [ Time Frame: October 2010 - December 2012 ]
  • 24 hour urinary sodium [ Time Frame: October -December 2012 ]

Secondary Outcome Measures:
  • 24 hour urinary potassium [ Time Frame: October-December 2012 ]
  • Urinary sodium:potassium ratio [ Time Frame: October-December 2012 ]
  • Receiving regular primary care [ Time Frame: October 2010 -December 2012 ]
  • Taking anti-hypertensive medications [ Time Frame: October 2010 -December 2012 ]
  • Taking aspirin [ Time Frame: October 2010 -December 2012 ]
  • Receiving therapeutic lifestyle recommendations from village doctors [ Time Frame: Oct 2010 - Dec 2012 ]

Other Outcome Measures:
  • Knowledge, attitude and behaviour relating to salt consumption [ Time Frame: October-December 2012 ]
  • Awareness, treatment, and control of hypertension [ Time Frame: October 2010 - December 2012 ]

Enrollment: 120
Study Start Date: December 2010
Study Completion Date: June 2014
Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: High risk management Behavioral: High-risk patient standardized management package
A primary-care based high cardiovascular risk management package delivered by village doctors
Other Name: high risk management
Experimental: Salt reduction Behavioral: Community based salt reduction program
A community-based salt reduction program delivered mainly by community health educators
Other Name: Salt reduction
Experimental: high risk management and salt reduction Behavioral: High-risk patient standardized management package
A primary-care based high cardiovascular risk management package delivered by village doctors
Other Name: high risk management
Behavioral: Community based salt reduction program
A community-based salt reduction program delivered mainly by community health educators
Other Name: Salt reduction
No Intervention: Usual care

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Physician-diagnosed history of coronary heart disease, ischemic stroke, or hemorrhagic stroke, or
  • Older age (50 years or older for men; 60 years or older for women) and having physician-diagnosed Type I or Type II diabetes
  • Older age (50 years or older for men; 60 years or older for women) and systolic blood pressure 160 mmHg (note that for simplicity, diastolic blood pressure is not included in the criteria)

Exclusion Criteria:

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01259700


Locations
China, Hebei
Hebei Province Center for Disease Prevention and Control ,China
Shijiazhuang, Hebei, China
China, Liaoning
The First Hospital Of China Medical University
Shenyang, Liaoning, China
China, Ningxia
Ningxia Medical University School of Public Health
Yinchuan, Ningxia, China
China, Shanxi
Changzhi Medical College, China
Changzhi, Shanxi, China
The Xi'an Jiaotong University School of Public Health
Xi'an, Shanxi, China
Sponsors and Collaborators
The George Institute for Global Health, China
National Heart, Lung, and Blood Institute (NHLBI)
Investigators
Principal Investigator: Yangfeng Wu, PhD The George Institute for Global Health, China
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: The George Institute for Global Health, China
ClinicalTrials.gov Identifier: NCT01259700     History of Changes
Other Study ID Numbers: Pro00025963
HHSN268200900027C ( Other Grant/Funding Number: US NIH NHLBI (BAA contract) )
First Submitted: December 13, 2010
First Posted: December 14, 2010
Last Update Posted: February 17, 2016
Last Verified: February 2016

Keywords provided by The George Institute for Global Health, China:
High blood pressure
Primary care
Cardiovascular disease prevention
Salt reduction

Additional relevant MeSH terms:
Cardiovascular Diseases